Approval · Notice of Compliance 31848 · 2023
DUOKOPT: Notice of Compliance 31848
Issued October 12, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31848
- Date
- October 12, 2023
- Company
- Laboratoires ThéaClermont-Ferrand, Cedex 2, France
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Replacement or addition of a drug product manufacturer / manufacturing site, involving production
- Canadian reference product
- COSOPT (Purdue Pharma)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DUOKOPT | Not yet assigned | — |
Medicinal ingredients
- TIMOLOL MALEATE 5 MG per ML
- DORZOLAMIDE HYDROCHLORIDE 20 MG per ML